Berberine's glucose and lipid effects appear at 900 to 1,500 mg daily in divided doses, a range replicated across multiple meta-analyses (Liang et al., 2019, 28 trials, 2,313 patients)
But heres what we know from recent research: A 2025 study presented at ENDO showed that postmenopausal women using tirzepatide plus hormone replacement therapy (HRT) lost significantly more weight (17% total body weight) compared to women using tirzepatide alone (14%)
Fecal and plasma metabolomics were later used to map the underlying sequence of events
HPLC purity, LC-MS identity, disulfide bond integrity, and LAL endotoxin readings are scored against pre-locked specifications, and full pass across all four assays is required before any lot is cleared into saleable inventory
Retatrutide might work best in adults with obesity or metabolic conditions who have surplus visceral fat